Posttranscriptional depletion of ribosome biogenesis factors engenders therapeutic vulnerabilities in NPM1-mutant AML. - Damaskou A; Wilson R; Gozdecka M; Giotopoulos G; Asby R; Eleftheriou M; Gu M; Récher C; Mansat-De Mas V; Vergez F; Sahal A; Vick B; et al. (Blood, 2025)